Clinical Trials List
2023-08-01 - 2036-12-31
Phase III
Recruiting8
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Hui Lee Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Kuo-Ting Lee Division of General Surgery
- Jui-Hung Tsai Division of Hematology & Oncology
- Yao-Lung Kuo Division of General Surgery
- Shang-Hung Chen Division of Hematology & Oncology
- Zhu-Jun Loh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李蕙鳴 Division of Hematology & Oncology
- 洪朝明 Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
- Meng-Jer Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李佳真 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 羅喬 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- MING-YANG WANG Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Hsin-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Chung Wu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- 黃至豪 Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
4300 participants
